Skip to main content
. 2021 Apr 12;52(7):738–745. doi: 10.1016/j.arcmed.2021.04.001

Table 1.

Demographic characteristics and prevalence of comorbidities

Characteristic Total (n = 528 651) Confirmed cases (n = 202 951) Negative cases (n = 262 117) Suspected cases (n = 63 583)
Female n (%) 260 477 (49.3) 91 652 (45.2) 137 730 (52.5) 31 095 (48.9)
Male n (%) 268 174 (50.7) 111 299 (54.8) 124 387 (47.5) 32 488 (51.1)
Age, years median (RIQ) 41 (31, 53) 45 (34, 57) 39 (29, 50) 41 (31, 54)
Death n (%) 33 596 (6.4) 25 060 (12.3) 6 570 (2.5) 1 966 (3.1)
DM2 n (%) 66 047 (12.5) 33 492 (16.6) 24 740 (9.5) 7 815 (12.4)
Hypertension n (%) 86 251 (16.4) 40 814 (20.2) 35 057 (13.4) 10 380 (16.4)
Obesity n (%) 86 339 (16.4) 39 873 (19.7) 36 461 (13.9) 10 005 (15.8)
CVD n (%) 12 047 (2.3) 4 802 (2.4) 5 977 (2.3) 1 268 (2.0)
CKD n (%) 10 605 (2.0) 4 434 (2.2) 4 974 (1.9) 1 197 (1.9)
Smoking n (%) 45 043 (8.5) 15 877 (7.9) 24 388 (9.3) 4 778 (7.6)
COPD n (%) 8 667 (1.6) 3 607 (1.8) 4 214 (1.6) 846 (1.3)
Asthma n (%) 17 025 (3.2) 5 610 (2.8) 9689 (3.7) 1 726 (2.7)
MetS components Prevalences
Cero, n (%) 352 902 (66.8) 121 176 (59.7) 188 852 (72) 42 874 (67.4)
One, n (%) 112 743 (21.3) 50 673 (25.0) 48 978 (18.7) 13 092 (20.6)
Two, n (%) 45 867 (8.7) 22 679 (11.2) 17 673 (6.7) 5 515 (8.7)
Three, n (%) 13 289 (2.5) 6667 (3.3) 5 064 (1.9) 1 558 (2.5)
Four, n (%) 1 414 (0.3) 641 (0.3) 621 (0.2) 152 (0.2)

DM2: diabetes mellitus 2; CVD: cardiovascular disease; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; MetS: metabolic syndrome. RIQ: Interquartile Range.